November 7, 2024

Investors should pay attention to the value of these 3 trending stocks – 3 trending stocks to watch out for today


Mumbai – Major indices of the capital market recovered somewhat in the later session from the initial decline. The Nifty index registered a level above 18,550. Meanwhile, information technology stocks maintained their bullish trend for the third consecutive session. The S&P BSE Sensex was up 52.47, or 0.13%, at 62,647.71 by 11:28 am on Thursday. The Nifty50 index rose by 23.25 points. In the broader market, the S&P BSE Midcap index rose by 0.42%. While the S&P BSE Smallcap index rose by 0.81%. Thursday’s session saw a bullish-bearish picture in the major indices till afternoon trade. During this time 3 notable stocks recorded noteworthy price movements. Investors should keep an eye on such stocks:

This article is published by Dalal Street Investment Journal, India’s No. 1 investment magazine. Click here and join to receive regular shares and recommendations from Teji.

Apollo Hospital : Share prices of Apollo Hospitals rose over 4% during the opening session on June 1 due to the company’s growth strategy. After a profitable performance in the March quarter, the management has planned to prepare for further growth. Sunita Reddy, managing director of Apollo Hospitals, said at the conclusion that the company has set a target of achieving 70% bed occupancy for its core hospital business by the end of financial year 2023-24. In the fourth quarter, this level is 64%.

Bajaj Auto : Bajaj Auto’s share price rose around 2 percent in the opening session on June 1 after the company announced revised sales figures for May 2023. Bajaj Auto reported a significant increase in overall sales, reaching 29% growth. Total sales increased by 29 percent to 3.55 lakh in May 2022. Domestic sales increased by 103 percent to 2.28 lakh.

Laurus Lab: The company’s decision to buy more stake in the advanced cell and gene therapy company led to a 3% increase in share price during June 1. Laurus Labs has finalized an agreement to purchase an additional 7.24% stake in ImmunoAdaptive Cell Therapy Pvt Ltd (lmmunoACT) for a cash consideration of Rs 80 crore.
Disclaimer: This above is third party content and TIL hereby disclaims any and all warranties, express or implied, relating to the same. TIL does not guarantee, vouch for or endorse any of the above content or its accuracy nor is responsible for it in any manner whatsoever. The content does not constitute any investment advice or solicitation of any kind. Users are advised to check with certified experts before taking any investment decision and take all steps necessary to ascertain that any information and content provided is correct, updated and verified.



Blog Source

Click here to Open Free Demat Account